| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 712.91M | 687.41M | 623.98M | 590.90M | 565.93M | 508.37M |
| Gross Profit | 224.76M | 207.48M | 171.73M | 180.82M | 165.88M | 137.66M |
| EBITDA | 100.32M | 97.48M | 81.94M | 86.38M | 81.02M | 59.72M |
| Net Income | 56.55M | 46.65M | 38.48M | 43.62M | 41.68M | 24.51M |
Balance Sheet | ||||||
| Total Assets | 606.78M | 571.44M | 553.21M | 550.92M | 555.36M | 558.51M |
| Cash, Cash Equivalents and Short-Term Investments | 19.45M | 26.71M | 45.59M | 31.45M | 66.13M | 45.68M |
| Total Debt | 223.88M | 103.24M | 108.75M | 121.98M | 138.80M | 153.00M |
| Total Liabilities | 409.78M | 359.37M | 341.11M | 339.76M | 349.53M | 349.49M |
| Stockholders Equity | 197.00M | 212.07M | 212.10M | 211.15M | 205.83M | 209.02M |
Cash Flow | ||||||
| Free Cash Flow | 21.13M | 33.11M | 57.71M | 21.31M | 73.08M | 37.57M |
| Operating Cash Flow | 36.87M | 49.73M | 60.07M | 25.12M | 75.70M | 54.66M |
| Investing Cash Flow | -15.74M | -18.12M | -2.94M | -18.16M | -2.62M | -17.09M |
| Financing Cash Flow | -27.37M | -48.86M | -44.48M | -38.95M | -51.99M | -19.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $1.24B | 22.81 | 29.05% | 1.04% | 9.28% | 44.19% | |
75 Outperform | $4.87B | 20.07 | 13.30% | ― | -0.95% | -10.54% | |
75 Outperform | $2.65B | 26.73 | 21.55% | ― | 8.99% | 35.56% | |
71 Outperform | $1.66B | 15.66 | 11.09% | 0.62% | -0.47% | 10.03% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | $151.59M | -0.79 | -61.44% | 9.25% | -10.83% | -1669.11% | |
48 Neutral | $177.66M | -1.98 | -44.74% | ― | -9.11% | -6082.17% |
CRA International’s recent earnings call painted a picture of robust financial health and strategic success, with a positive sentiment prevailing despite some challenges. The company reported strong revenue growth across multiple practices, particularly in Antitrust & Competition Economics, and celebrated record-setting first-half results. These achievements led to an increase in revenue guidance, overshadowing concerns about headcount reductions, challenges in the Life Sciences practice, and high debt levels.
Charles River Associates (CRA) is a global consulting firm specializing in economic, financial, and management consulting services, providing expert advice on economic and financial matters related to litigation, regulatory proceedings, and business strategy.
On July 31, 2025, Charles River Associates announced a quarterly cash dividend of $0.49 per share, payable on September 12, 2025, to shareholders of record as of August 26, 2025. The company reported record quarterly revenue of $186.9 million for the second quarter of 2025, driven by broad-based contributions across several practices and geographic regions. CRA also increased its revenue guidance for the full fiscal year 2025, reflecting strong business momentum and demand for its services.
The most recent analyst rating on (CRAI) stock is a Buy with a $212.00 price target. To see the full list of analyst forecasts on Cra International stock, see the CRAI Stock Forecast page.